As Drug Discovery Tackles More Difficult Challenges, Lilly Wants To Help

No-Strings Agreements May Evolve To Future Deals

 
• By Mandy Jackson
  
Lilly Gateway Labs San Diego is the big pharma's fifth accelerator site (Alexandria Real Estate Equities Inc.)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Start-Ups & SMEs

More from Business